Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of β-chloroethylnitrosourea compound and its synthesis method and application

A technology of chloroethyl nitroso compounds, which is applied in the fields of active ingredients of heterocyclic compounds, drug combinations, organic chemistry, etc. It can solve the problems of undiscovered compounds, non-targeted inhibitory effects, and increased toxic and side effects of chemotherapy drugs. And other issues

Active Publication Date: 2016-03-09
BEIJING UNIV OF TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the study found that due to O 6 AGT inhibition by benzylguanine is not on-target
In combination with CENU, O 6 -Benzylguanine can not selectively target tumor cells to exert its inhibitory effect on AGT, but simultaneously acts on normal cells non-targetedly, causing AGT in normal cells to be inhibited, thus destroying the DNA damage of normal cells Repair mechanism that increases the risk of DNA damage in normal cells, ultimately leading to increased toxicity of chemotherapy drugs
[0008] After searching, no related reports of the compounds provided by the invention have been found

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of β-chloroethylnitrosourea compound and its synthesis method and application
  • A kind of β-chloroethylnitrosourea compound and its synthesis method and application
  • A kind of β-chloroethylnitrosourea compound and its synthesis method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Embodiment 1:1-(O 6 -Synthesis of [2-(aminomethyl)benzyl]guanine)-3-(2-chloroethyl)-1-nitrosourea (Compound 1).

[0087] (1) Synthesis of 1-(2-amino-9-hydrogen-purine-6-)-1-methylpyrrolidine chloride

[0088] Dissolve 2g of 2-amino-6-chloropurine (11.8mmol) in 40mL of N,N-dimethylformamide, add 2.8mL of 1-methylpyrrolidine (26.4mmol), and mix and stir for 18 hours at 25°C. After the reaction is complete, Add 4mL of acetone, precipitation occurs, filter, the collected solid is washed twice with ether, and vacuum-dried to obtain 1-(2-amino-9-hydrogen-purine-6-)-1-methylpyrrolidine chloride ( 2.6 g, 8.2 mmol), yield 66%.

[0089] UV lambda: 289nm;

[0090] IR (KBr tablet) v / cm -1 : 3445.4(NH), 3274.9(NH 2 ), 2974.9(C-H), 1719.3(C=N), 1552.7(C=C);

[0091] 1 H-NMR (DMSO-d 6 )δ: 2.04(m,2H,CH 2 ),2.23(m,2H,CH 2 ),3.64(s,3H,CH 3 ),3.94(m,2H,CH 2 N + ),4.58(m,2H,CH 2 N + ),7.13(s,2H,NH 2 ),8.31(s,1H,H8),12.99(s,1H,H9);

[0092] ESI-MS: 255[M+H] + .

[0093] (...

Embodiment 2

[0126] Embodiment 2:1-(O 6-Synthesis of [3-(aminomethyl)benzyl]guanine)-3-(2-chloroethyl)-1-nitrosourea (Compound 2).

[0127] (1) Synthesis of 1-(2-amino-9-hydrogen-purine-6-)-1-methylpyrrolidine chloride: the method is the same as step (1) in Example 1.

[0128] (2) 3-[(trifluoroacetamido)methyl]-benzyl alcohol

[0129] Dissolve 3.4g of 3-(aminomethyl)-benzyl alcohol (24.8mmol) and 3.52mL of triethylamine (24.8mmol) in 50mL of anhydrous methanol, and add 3.92mL of ethyl trifluoroacetate (32.8mL) dropwise under argon protection. mmol), stirred and reacted at 25° C. for 2 hours, after the reaction was finished, 50 mL of ethyl acetate and 50 mL of water were added for extraction, the ethyl acetate layer was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and the solvent was removed in vacuo to obtain 3 -[(trifluoroacetamido)methyl]-benzyl alcohol crude product, the crude product was purified by silica gel column chromatography, the...

Embodiment 3

[0161] Example 3: 1-(O 6 Synthesis of -[4-(aminomethyl)benzyl]guanine)-3-(2-chloroethyl)-1-nitrosourea (compound 3)

[0162] (1) Synthesis of 1-(2-amino-9-hydrogen-purine-6-)-1-methylpyrrolidine chloride: the method is the same as step (1) in Example 1.

[0163] (2) 4-[(trifluoroacetamido)methyl]-benzyl alcohol

[0164] 2.55g of 4-(aminomethyl)-benzyl alcohol (18.6mmol) and 2.64mL of triethylamine (18.6mmol) were dissolved in 25mL of anhydrous methanol, and 2.94mL of ethyl trifluoroacetate (24.6 mmol), stirred at 25°C for 2 hours. After the reaction was completed, 35 mL of ethyl acetate and 35 mL of water were added for extraction, the ethyl acetate layer was washed with saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and the solvent was removed in vacuo to obtain 4-[(trifluoroacetamido)formazan base]-benzyl alcohol crude product. The crude product was purified by silica gel column chromatography, and the eluent was ethyl acetate / cyclohexan...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to novel beta-chloroethylnitrosourea compounds, and a synthesis method and application thereof. The structure of the beta-chloroethylnitrosourea compounds is disclosed as general formula (II). The in-vitro antitumor screening test on the compounds disclosed as general formula II proves that the compounds disclosed as general formula I have obvious inhibiting action on human cerebral nerve glioma cells SF763, SF767, SF126 and SF188, human colon cancer cell HT29, mouse leukaemia cell L1210 and many other tumor cell lines and have higher tumor inhibiting activity than the existing CENU and CENU / O6-benzylguanine combined medicine.

Description

technical field [0001] The present invention relates to a nitrosourea compound and its synthesis method and use, in particular to a novel β-chloroethyl nitrosourea compound, its synthesis method and its use in the preparation of antitumor drugs. Background technique [0002] Nitrosourea compounds are antitumor drugs widely used clinically. The American Cancer Research Center found that N-methyl-N-nitrosourea is effective for transplantation of L1210 leukemia in the 1960s (Schepartz, S.A. Cancer Treat. Rep. 1976, 60, 647-649.), and then conducted research on the structure of this class of drugs During the transformation process, it was found that when the methyl group at the β position was replaced by a chloroethyl group, the anticancer activity of the drug increased significantly, and a series of β-chloroethylnitrosourea (CENU) compounds (such as formula I shown) (Gnewuch, C.T.; Sosnovsky, G. Chem. Rev. 1997, 97, 829-1013.). [0003] [0004] Since CENU has strong fat s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D473/18A61K31/52A61P35/00A61P35/02
CPCC07D473/18
Inventor 赵丽娇孙国辉钟儒刚
Owner BEIJING UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products